The BPIA 2026 Annual Meeting held in Washington, DC on March 4-6 included three tracks covering a variety of regulatory, technical, and commercial topics with speakers from EPA, USDA, CFIA, PMRA, and AAPFCO.
The BPIA 2026 Annual Meeting held in Washington, DC on March 4-6 included three tracks covering a variety of regulatory, technical, and commercial topics with speakers from EPA, USDA, CFIA, PMRA, and AAPFCO.
As we reflect on 2025, BPIA would like to thank all our partners for their continued engagement and help in promoting the biological products industry.
BPIA applauds last week’s announcement from the USDA in collaboration with HHS launching a $700 million Regenerative Pilot Program.
The Biological Products Industry Alliance (BPIA) promotes the responsible development of safe and effective biological products including biopesticides, biostimulants, and biofertilizers as beneficial tools for commercial agriculture, forestry, golf courses, home gardens, horticulture, ornamentals, public health, and more through education, outreach, and advocacy activities at the state, federal, and international levels. Our members provide solutions that benefit growers, consumers, and the environment.